GLYCOTUP

Novel Chemical Probes for Tuberculosis Diagnosis and Treatment

Coordinatore	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD    more  Organization address address: University Offices, Wellington Square city: OXFORD postcode: OX1 2JD contact info Titolo: Ms. Nome: Linda Cognome: Polik Email: send email Telefono: +44 1865 289811 Fax: +44 1865 289801
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	178˙307 €
EC contributo	178˙307 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2007-2-1-IEF
Funding Scheme	MC-IEF
Anno di inizio	2008
Periodo (anno-mese-giorno)	2008-03-27   -   2010-03-26

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD  Organization address address: University Offices, Wellington Square city: OXFORD postcode: OX1 2JD contact info Titolo: Ms. Nome: Linda Cognome: Polik Email: send email Telefono: +44 1865 289811 Fax: +44 1865 289801	UK (OXFORD)	coordinator	0.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Tuberculosis (TB) is a common and deadly infectious disease caused by mycobacteria, mainly Mycobacterium tuberculosis (MTB). In the developed world, the advent of powerful antibiotics and a concerted inoculation program saw the near extinction of TB. However, the rise of drug-resistant strains, HIV infections, and the neglect of TB control programs have increased the urgency for an alternative treatment and diagnosis. Since the presence of L-rhamnose and trehalose [α-D-Glc-(1↔1)-α-D-Glc] motifs in MTB have been associated with disease states, the preparation of modified derivatives constitute excellent research tools to investigate the infective process and offer themselves as potential therapeutic agents. These two sugars are not found in mammalian biology and therefore provide a powerful handle for distinguishing pathogen (MTB) from host (man) both during diagnosis and treatment. In particular, 2-deoxy-2-fluoroglycosides are compounds of increasing importance in biochemistry and medicinal research, especially as antiviral agents, cancer diagnosis probes, and labelling substrates for many biological studies. In addition, 2-deoxy-2-fluoroglycosides have been found particularly useful in the determination of the molecular mechanism of glycosidases and glycosyltransferases by trapping key enzymatic intermediates. We propose a program targeted at the development of innovative methodologies for the preparation of fluorosugars and glycolipid analogues that will allow direct imaging and treatment of TB. The specific goals include: a) Synthesis of 2-deoxy-2-fluoro-rhamnose and trehalose derivatives. b) Synthesis of CD1b-binding glycolipids with variations either at the glycoside and the lipid moieties. c) The use of fluoroglycosides as mechanistic probes, inhibitors, and imaging agents (alternative TB treatment and diagnosis: 18F PET and 19F NMR/MRI).'